16-75542602-C-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The ENST00000258173.11(TMEM231):c.664G>A(p.Val222Ile) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,613,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V222L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000258173.11 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM231 | NM_001077418.3 | c.664G>A | p.Val222Ile | missense_variant, splice_region_variant | 5/7 | ENST00000258173.11 | NP_001070886.1 | |
TMEM231 | NM_001077416.2 | c.823G>A | p.Val275Ile | missense_variant, splice_region_variant | 4/6 | NP_001070884.2 | ||
TMEM231 | NR_074083.2 | n.830G>A | splice_region_variant, non_coding_transcript_exon_variant | 5/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM231 | ENST00000258173.11 | c.664G>A | p.Val222Ile | missense_variant, splice_region_variant | 5/7 | 1 | NM_001077418.3 | ENSP00000258173 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152084Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249246Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135220
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461414Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727020
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152084Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74286
ClinVar
Submissions by phenotype
Meckel syndrome, type 11 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 14, 2020 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2013 | - - |
Joubert syndrome 20;C3809352:Meckel syndrome, type 11 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 08, 2023 | This sequence change affects codon 275 of the TMEM231 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the TMEM231 protein. This variant also falls at the last nucleotide of exon 4, which is part of the consensus splice site for this exon. This variant is present in population databases (rs397514753, gnomAD 0.01%). This variant has been observed in individual(s) with Meckel syndromes (PMID: 23349226, 25869670). ClinVar contains an entry for this variant (Variation ID: 64619). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Not Available"; Align-GVGD: "Not Available". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant is associated with altered splicing resulting in multiple RNA products (PMID: 23349226). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Dec 15, 2021 | - - |
Meckel-Gruber syndrome Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Dec 01, 2014 | - - |
TMEM231-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 19, 2024 | The TMEM231 c.823G>A variant is predicted to result in the amino acid substitution p.Val275Ile. This variant, reported as c.751G>A, was reported in the homozygous state in a fetus with Meckel-Gruber syndrome (Shaheen et al. 2013. PubMed ID: 23349226). The c.823G>A is the terminal nucleotide of exon 4 adjacent to the GT donor site. Functional studies found that this variant interferes with normal splicing (Shaheen et al. 2013. PubMed ID: 23349226; Maddirevula et al. 2020. PubMed ID: 32552793, Table S1). This variant is reported in 0.012% of alleles in individuals of African descent in gnomAD. This variant is interpreted as likely pathogenic. - |
Joubert syndrome 20 Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 17, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at